Profile data is unavailable for this security.
About the company
Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is an acellular resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen-based nerve wrap designed to support nerve repair surgery in peripheral nerve repair. OrthoACI, or Autologous Chondrocyte Implantation, offers treatment for symptomatic defects of the articulating cartilage of the joints. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.
- Revenue in AUD (TTM)8.85m
- Net income in AUD-8.57m
- Incorporated2006
- Employees--
- LocationOrthocell LtdBuilding 191 Murdoch UniversitySouth Street MurdochPERTH 6150AustraliaAUS
- Phone+61 89360-2888
- Fax+61 89360-2899
- Websitehttps://orthocell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epiminder Ltd | -100.00bn | -100.00bn | 138.40m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -93.22 | -- | -99.64 | -- | -- | -- |
| Somnomed Ltd | 111.52m | -3.46m | 151.82m | 300.00 | -- | 3.24 | 66.29 | 1.36 | -0.0163 | -0.0163 | 0.5262 | 0.2147 | 1.48 | 6.53 | 7.25 | -- | -4.58 | -9.15 | -6.76 | -13.46 | 59.86 | 60.62 | -3.10 | -6.89 | 1.25 | -0.6067 | 0.1475 | -- | 21.63 | 14.24 | 71.77 | -- | 12.72 | -- |
| EMvision Medical Devices Ltd | 5.63m | -9.81m | 167.29m | -- | -- | 16.58 | -- | 29.72 | -0.1148 | -0.1148 | 0.0659 | 0.1086 | 0.2847 | -- | 694.01 | -- | -49.59 | -47.15 | -58.91 | -58.42 | -- | -- | -174.21 | -105.97 | -- | -93.34 | 0.2758 | -- | -51.31 | 41.83 | -259.23 | -- | -- | -- |
| Lumos Diagnostics Holdings Ltd | 17.49m | -10.13m | 218.13m | -- | -- | 23.71 | -- | 12.47 | -0.0147 | -0.0147 | 0.0257 | 0.0116 | 0.5205 | 7.04 | 4.91 | -- | -30.15 | -40.19 | -54.60 | -61.16 | 62.95 | 52.57 | -57.93 | -132.46 | 0.6816 | -10.69 | 0.5315 | -- | 11.40 | 17.12 | 16.40 | -- | -61.58 | -- |
| Aroa Biosurgery Ltd | 77.16m | -1.55m | 234.92m | 261.00 | -- | 2.98 | 139.65 | 3.04 | -0.0045 | -0.0045 | 0.2236 | 0.2285 | 0.8432 | 1.56 | 3.08 | -- | -1.70 | -8.53 | -1.85 | -9.75 | 85.07 | 82.71 | -2.01 | -15.20 | 5.74 | 0.3142 | 0.0706 | -- | 22.63 | 27.56 | 64.12 | -- | 14.62 | -- |
| Orthocell Ltd | 8.85m | -8.57m | 271.31m | -- | -- | 16.70 | -- | 30.65 | -0.0375 | -0.0375 | 0.0397 | 0.0599 | 0.2862 | 2.31 | 9.20 | -- | -27.70 | -28.14 | -34.17 | -33.47 | 68.98 | 71.87 | -96.78 | -167.82 | 4.78 | -- | 0.0381 | -- | 36.41 | 61.65 | -19.30 | -- | 45.43 | -- |
| Saluda Medical Inc | -100.00bn | -100.00bn | 297.39m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 36.13 | -- | -52.62 | -- | -- | -- |
| EchoIQ Ltd | 101.41k | -13.26m | 310.55m | -- | -- | 13.47 | -- | 3,062.31 | -0.0226 | -0.0226 | 0.0002 | 0.0353 | 0.0064 | -- | 0.6446 | -- | -83.87 | -68.78 | -89.84 | -81.95 | -- | -- | -13,078.12 | -3,892.98 | -- | -- | 0.00 | -- | 127.89 | -31.65 | -145.19 | -- | -16.56 | -- |
| Paragon Care Ltd | 3.62bn | 20.57m | 331.06m | 0.00 | 16.10 | 1.00 | 6.57 | 0.0915 | 0.0124 | 0.0124 | 2.18 | 0.1993 | 3.02 | 11.90 | 10.33 | -- | 1.72 | 1.79 | 4.47 | 4.07 | 9.04 | 8.90 | 0.5688 | 0.6081 | 0.6155 | 1.77 | 0.4699 | -- | 21.72 | 73.23 | 151.52 | -- | 18.34 | -- |
| EBR Systems Inc | 961.49k | -63.19m | 382.53m | -- | -- | 7.02 | -- | 397.85 | -0.1688 | -0.1688 | 0.0025 | 0.1212 | 0.0074 | -- | 0.4935 | -- | -48.75 | -60.71 | -53.75 | -74.76 | 45.20 | -- | -6,572.14 | -- | 7.01 | -15.00 | 0.5131 | -- | -- | -- | -16.44 | -- | 2.46 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Wyllie Group Pty Ltd.as of 20 Aug 2025 | 4.61m | 1.70% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 538.32k | 0.20% |
